Stock Taper 
BDX
$188.11
▼ DOWN 0.74% (-1.41)
KEY STATISTICS
Market Cap$51.81 B
52w High$193.07
52w Low$127.59
Dividend Yield2.40%
FrequencyQuarterly
P/E14.47
Volume2.63M
Shares Out.275.54M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Thomas E. Polen Jr.
COMPENSATION 2026
Salary$1,395,463
Stock Awards$9,991,854
Incentive Plan Pay$1,852,010
All Other Comp.$577,951
Total$17,129,140
ABOUT
SECTOR
Healthcare
WENT PUBLIC
February 21, 1973
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
72,000
PRICE TARGET
Target High$210.00
Target Low$159.00
Target Median$190.00
Target Consensus$186.88
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$5.11B
NOV
5
THU
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-02-10 | Forward | 159:125 |
| 2022-04-01 | Forward | 41:40 |
| 1998-08-21 | Forward | 2:1 |
| 1996-08-16 | Forward | 2:1 |
| 1993-03-01 | Forward | 2:1 |
| 1986-03-03 | Forward | 2:1 |
PRICE
$188.11 ▼ DOWN 0.74% (−$1.41)About Becton, Dickinson and Company
https://www.bd.com ↗Becton, Dickinson and Company develops and sells medical supplies, devices, and diagnostic products worldwide across segments including medical, life sciences, and interventional healthcare.
INDUSTRY
Medical - Instruments & Supplies
A PRODUCT BECTON, DICKINSON AND COMPANY IS KNOWN FOR
BD Pyxis Pro Automated Medication Dispensing Solution
The BD Pyxis Pro, launched in October 2025, is an advanced automated medication cabinet with increased capacity, enhanced security, and integration into BD's AI-driven Incada™ platform to improve medication management and healthcare efficiency.
Revenue by Products
| Icon | PRODUCT | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|---|
 | Life Sciences | $1.25B | $1.25B ▲ | $1.37B ▲ | $2.5B ▲ |
 | Medical | $2.76B | $2.93B ▲ | $3.15B ▲ | $2.4B ▼ |
 | Interventional | $1.26B | $1.33B ▲ | $1.37B ▲ | — |
Revenue by Geography
| Map | REGION | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|---|
 | UNITED STATES | $3.11B | $3.18B ▲ | $3.42B ▲ | $3.16B ▼ |
 | NonUS | $2.16B | $2.33B ▲ | — | $2.09B ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
273
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
64.90%
HOLDERS
2,361
TOP 12 OF 2,361 · RANKED BY POSITION SIZE
Vanguard Group Inc
Blackrock, Inc.
Blackrock Inc.
T. Rowe Price Investment Management, Inc.
State Street Corp
First Eagle Investment Management, LLC
Invesco Ltd.
Massachusetts Financial Services Co /Ma/
Geode Capital Management, LLC
Franklin Resources Inc
Wellington Management Group Llp
Blackrock Institutional Trust Company, N.A.
RATINGS SNAPSHOT
Overall rating: B
Discounted Cash Flow5
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score3
TRADES BY CONGRESS
HOUSE TRADES
Thomas H. Kean
Sale
2026-05-21
Kevin Hern
Sale
2026-03-17
Ro Khanna
Purchase
2025-09-29
Lisa McClain
Sale (Full)
2025-06-24
INSIDER TRADES
★
OFFICER: EVP, CHIEF REVENUE OFFICER
Feld Michael
Sale · 165 shares
2026-08-26
★
OFFICER: EVP, CHIEF REVENUE OFFICER
Feld Michael
Sale · 1.0K shares
2026-08-20
★
DIRECTOR, OFFICER: CHAIRMAN, CEO AND PRESIDENT
Polen Thomas E Jr
Sale · 4.2K shares
2026-08-13
★
DIRECTOR, OFFICER: CHAIRMAN, CEO AND PRESIDENT
Polen Thomas E Jr
Sale · 39.1K shares
2026-08-13
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 4
NEUTRAL 3
OVERWEIGHT 2
SECTOR PERFORM 1
EQUAL WEIGHT 1
HOLD 1
OUTPERFORM 1
13 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ARGX | $1025.14 | COMPARE |
 CAH | $235.55 | COMPARE |
 EW | $90.88 | COMPARE |
 VEEV | $290.25 | COMPARE |
 HLN | $10.07 | COMPARE |
 IDXX | $558.10 | COMPARE |
 A | $152.68 | COMPARE |
 IQV | $260.14 | COMPARE |